Request for Covid-19 Impact Assessment of this Report
The United States Blood Coagulants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Blood Coagulants market, reaching US$ million by the year 2028. As for the Europe Blood Coagulants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Blood Coagulants players cover Pfizer, Bayer, Novo Nordisk, and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Coagulants market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Recombinant Coagulation Factor
Plasma Coagulation Factor
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Coagulants Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Blood Coagulants by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Blood Coagulants by Country/Region, 2017, 2022 & 2028
2.2 Blood Coagulants Segment by Type
2.2.1 Recombinant Coagulation Factor
2.2.2 Plasma Coagulation Factor
2.3 Blood Coagulants Sales by Type
2.3.1 Global Blood Coagulants Sales Market Share by Type (2017-2022)
2.3.2 Global Blood Coagulants Revenue and Market Share by Type (2017-2022)
2.3.3 Global Blood Coagulants Sale Price by Type (2017-2022)
2.4 Blood Coagulants Segment by Sale Channel
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Blood Coagulants Sales by Sale Channel
2.5.1 Global Blood Coagulants Sale Market Share by Sale Channel (2017-2022)
2.5.2 Global Blood Coagulants Revenue and Market Share by Sale Channel (2017-2022)
2.5.3 Global Blood Coagulants Sale Price by Sale Channel (2017-2022)
3 Global Blood Coagulants by Company
3.1 Global Blood Coagulants Breakdown Data by Company
3.1.1 Global Blood Coagulants Annual Sales by Company (2020-2022)
3.1.2 Global Blood Coagulants Sales Market Share by Company (2020-2022)
3.2 Global Blood Coagulants Annual Revenue by Company (2020-2022)
3.2.1 Global Blood Coagulants Revenue by Company (2020-2022)
3.2.2 Global Blood Coagulants Revenue Market Share by Company (2020-2022)
3.3 Global Blood Coagulants Sale Price by Company
3.4 Key Manufacturers Blood Coagulants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Coagulants Product Location Distribution
3.4.2 Players Blood Coagulants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blood Coagulants by Geographic Region
4.1 World Historic Blood Coagulants Market Size by Geographic Region (2017-2022)
4.1.1 Global Blood Coagulants Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Blood Coagulants Annual Revenue by Geographic Region
4.2 World Historic Blood Coagulants Market Size by Country/Region (2017-2022)
4.2.1 Global Blood Coagulants Annual Sales by Country/Region (2017-2022)
4.2.2 Global Blood Coagulants Annual Revenue by Country/Region
4.3 Americas Blood Coagulants Sales Growth
4.4 APAC Blood Coagulants Sales Growth
4.5 Europe Blood Coagulants Sales Growth
4.6 Middle East & Africa Blood Coagulants Sales Growth
5 Americas
5.1 Americas Blood Coagulants Sales by Country
5.1.1 Americas Blood Coagulants Sales by Country (2017-2022)
5.1.2 Americas Blood Coagulants Revenue by Country (2017-2022)
5.2 Americas Blood Coagulants Sales by Type
5.3 Americas Blood Coagulants Sales by Sale Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Coagulants Sales by Region
6.1.1 APAC Blood Coagulants Sales by Region (2017-2022)
6.1.2 APAC Blood Coagulants Revenue by Region (2017-2022)
6.2 APAC Blood Coagulants Sales by Type
6.3 APAC Blood Coagulants Sales by Sale Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood Coagulants by Country
7.1.1 Europe Blood Coagulants Sales by Country (2017-2022)
7.1.2 Europe Blood Coagulants Revenue by Country (2017-2022)
7.2 Europe Blood Coagulants Sales by Type
7.3 Europe Blood Coagulants Sales by Sale Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Coagulants by Country
8.1.1 Middle East & Africa Blood Coagulants Sales by Country (2017-2022)
8.1.2 Middle East & Africa Blood Coagulants Revenue by Country (2017-2022)
8.2 Middle East & Africa Blood Coagulants Sales by Type
8.3 Middle East & Africa Blood Coagulants Sales by Sale Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Coagulants
10.3 Manufacturing Process Analysis of Blood Coagulants
10.4 Industry Chain Structure of Blood Coagulants
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Coagulants Distributors
11.3 Blood Coagulants Customer
12 World Forecast Review for Blood Coagulants by Geographic Region
12.1 Global Blood Coagulants Market Size Forecast by Region
12.1.1 Global Blood Coagulants Forecast by Region (2023-2028)
12.1.2 Global Blood Coagulants Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood Coagulants Forecast by Type
12.7 Global Blood Coagulants Forecast by Sale Channel
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Blood Coagulants Product Offered
13.1.3 Pfizer Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Blood Coagulants Product Offered
13.2.3 Bayer Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Information
13.3.2 Novo Nordisk Blood Coagulants Product Offered
13.3.3 Novo Nordisk Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novo Nordisk Main Business Overview
13.3.5 Novo Nordisk Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Blood Coagulants Product Offered
13.4.3 Takeda Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 SOBI
13.5.1 SOBI Company Information
13.5.2 SOBI Blood Coagulants Product Offered
13.5.3 SOBI Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 SOBI Main Business Overview
13.5.5 SOBI Latest Developments
13.6 Octapharma
13.6.1 Octapharma Company Information
13.6.2 Octapharma Blood Coagulants Product Offered
13.6.3 Octapharma Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Octapharma Main Business Overview
13.6.5 Octapharma Latest Developments
13.7 CSL
13.7.1 CSL Company Information
13.7.2 CSL Blood Coagulants Product Offered
13.7.3 CSL Blood Coagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CSL Main Business Overview
13.7.5 CSL Latest Developments
14 Research Findings and Conclusion
Table 1. Blood Coagulants Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Blood Coagulants Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant Coagulation Factor
Table 4. Major Players of Plasma Coagulation Factor
Table 5. Global Blood Coagulants Sales by Type (2017-2022) & (K Units)
Table 6. Global Blood Coagulants Sales Market Share by Type (2017-2022)
Table 7. Global Blood Coagulants Revenue by Type (2017-2022) & ($ million)
Table 8. Global Blood Coagulants Revenue Market Share by Type (2017-2022)
Table 9. Global Blood Coagulants Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Blood Coagulants Sales by Sale Channel (2017-2022) & (K Units)
Table 11. Global Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Table 12. Global Blood Coagulants Revenue by Sale Channel (2017-2022)
Table 13. Global Blood Coagulants Revenue Market Share by Sale Channel (2017-2022)
Table 14. Global Blood Coagulants Sale Price by Sale Channel (2017-2022) & (USD/Unit)
Table 15. Global Blood Coagulants Sales by Company (2020-2022) & (K Units)
Table 16. Global Blood Coagulants Sales Market Share by Company (2020-2022)
Table 17. Global Blood Coagulants Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Blood Coagulants Revenue Market Share by Company (2020-2022)
Table 19. Global Blood Coagulants Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Blood Coagulants Producing Area Distribution and Sales Area
Table 21. Players Blood Coagulants Products Offered
Table 22. Blood Coagulants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Blood Coagulants Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Blood Coagulants Sales Market Share Geographic Region (2017-2022)
Table 27. Global Blood Coagulants Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Blood Coagulants Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Blood Coagulants Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Blood Coagulants Sales Market Share by Country/Region (2017-2022)
Table 31. Global Blood Coagulants Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Blood Coagulants Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Blood Coagulants Sales by Country (2017-2022) & (K Units)
Table 34. Americas Blood Coagulants Sales Market Share by Country (2017-2022)
Table 35. Americas Blood Coagulants Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Blood Coagulants Revenue Market Share by Country (2017-2022)
Table 37. Americas Blood Coagulants Sales by Type (2017-2022) & (K Units)
Table 38. Americas Blood Coagulants Sales Market Share by Type (2017-2022)
Table 39. Americas Blood Coagulants Sales by Sale Channel (2017-2022) & (K Units)
Table 40. Americas Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Table 41. APAC Blood Coagulants Sales by Region (2017-2022) & (K Units)
Table 42. APAC Blood Coagulants Sales Market Share by Region (2017-2022)
Table 43. APAC Blood Coagulants Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Blood Coagulants Revenue Market Share by Region (2017-2022)
Table 45. APAC Blood Coagulants Sales by Type (2017-2022) & (K Units)
Table 46. APAC Blood Coagulants Sales Market Share by Type (2017-2022)
Table 47. APAC Blood Coagulants Sales by Sale Channel (2017-2022) & (K Units)
Table 48. APAC Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Table 49. Europe Blood Coagulants Sales by Country (2017-2022) & (K Units)
Table 50. Europe Blood Coagulants Sales Market Share by Country (2017-2022)
Table 51. Europe Blood Coagulants Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Blood Coagulants Revenue Market Share by Country (2017-2022)
Table 53. Europe Blood Coagulants Sales by Type (2017-2022) & (K Units)
Table 54. Europe Blood Coagulants Sales Market Share by Type (2017-2022)
Table 55. Europe Blood Coagulants Sales by Sale Channel (2017-2022) & (K Units)
Table 56. Europe Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Table 57. Middle East & Africa Blood Coagulants Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Blood Coagulants Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Blood Coagulants Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Blood Coagulants Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Blood Coagulants Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Blood Coagulants Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Blood Coagulants Sales by Sale Channel (2017-2022) & (K Units)
Table 64. Middle East & Africa Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Blood Coagulants
Table 66. Key Market Challenges & Risks of Blood Coagulants
Table 67. Key Industry Trends of Blood Coagulants
Table 68. Blood Coagulants Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Blood Coagulants Distributors List
Table 71. Blood Coagulants Customer List
Table 72. Global Blood Coagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Blood Coagulants Sales Market Forecast by Region
Table 74. Global Blood Coagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Blood Coagulants Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Blood Coagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Blood Coagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Blood Coagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Blood Coagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Blood Coagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Blood Coagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Blood Coagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Blood Coagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Blood Coagulants Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Blood Coagulants Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Blood Coagulants Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Blood Coagulants Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Blood Coagulants Sales Forecast by Sale Channel (2023-2028) & (K Units)
Table 89. Global Blood Coagulants Sales Market Share Forecast by Sale Channel (2023-2028)
Table 90. Global Blood Coagulants Revenue Forecast by Sale Channel (2023-2028) & ($ Millions)
Table 91. Global Blood Coagulants Revenue Market Share Forecast by Sale Channel (2023-2028)
Table 92. Pfizer Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Blood Coagulants Product Offered
Table 94. Pfizer Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Bayer Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Blood Coagulants Product Offered
Table 99. Bayer Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. Novo Nordisk Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 103. Novo Nordisk Blood Coagulants Product Offered
Table 104. Novo Nordisk Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Novo Nordisk Main Business
Table 106. Novo Nordisk Latest Developments
Table 107. Takeda Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 108. Takeda Blood Coagulants Product Offered
Table 109. Takeda Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Takeda Main Business
Table 111. Takeda Latest Developments
Table 112. SOBI Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 113. SOBI Blood Coagulants Product Offered
Table 114. SOBI Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. SOBI Main Business
Table 116. SOBI Latest Developments
Table 117. Octapharma Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 118. Octapharma Blood Coagulants Product Offered
Table 119. Octapharma Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Octapharma Main Business
Table 121. Octapharma Latest Developments
Table 122. CSL Basic Information, Blood Coagulants Manufacturing Base, Sales Area and Its Competitors
Table 123. CSL Blood Coagulants Product Offered
Table 124. CSL Blood Coagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. CSL Main Business
Table 126. CSL Latest Developments
List of Figures
Figure 1. Picture of Blood Coagulants
Figure 2. Blood Coagulants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Coagulants Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Blood Coagulants Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Blood Coagulants Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant Coagulation Factor
Figure 10. Product Picture of Plasma Coagulation Factor
Figure 11. Global Blood Coagulants Sales Market Share by Type in 2021
Figure 12. Global Blood Coagulants Revenue Market Share by Type (2017-2022)
Figure 13. Blood Coagulants Consumed in Hospital
Figure 14. Global Blood Coagulants Market: Hospital (2017-2022) & (K Units)
Figure 15. Blood Coagulants Consumed in Pharmacy
Figure 16. Global Blood Coagulants Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Blood Coagulants Consumed in Other
Figure 18. Global Blood Coagulants Market: Other (2017-2022) & (K Units)
Figure 19. Global Blood Coagulants Sales Market Share by Sale Channel (2017-2022)
Figure 20. Global Blood Coagulants Revenue Market Share by Sale Channel in 2021
Figure 21. Blood Coagulants Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Blood Coagulants Revenue Market Share by Company in 2021
Figure 23. Global Blood Coagulants Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Blood Coagulants Revenue Market Share by Geographic Region in 2021
Figure 25. Global Blood Coagulants Sales Market Share by Region (2017-2022)
Figure 26. Global Blood Coagulants Revenue Market Share by Country/Region in 2021
Figure 27. Americas Blood Coagulants Sales 2017-2022 (K Units)
Figure 28. Americas Blood Coagulants Revenue 2017-2022 ($ Millions)
Figure 29. APAC Blood Coagulants Sales 2017-2022 (K Units)
Figure 30. APAC Blood Coagulants Revenue 2017-2022 ($ Millions)
Figure 31. Europe Blood Coagulants Sales 2017-2022 (K Units)
Figure 32. Europe Blood Coagulants Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Blood Coagulants Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Blood Coagulants Revenue 2017-2022 ($ Millions)
Figure 35. Americas Blood Coagulants Sales Market Share by Country in 2021
Figure 36. Americas Blood Coagulants Revenue Market Share by Country in 2021
Figure 37. United States Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Blood Coagulants Sales Market Share by Region in 2021
Figure 42. APAC Blood Coagulants Revenue Market Share by Regions in 2021
Figure 43. China Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Blood Coagulants Sales Market Share by Country in 2021
Figure 50. Europe Blood Coagulants Revenue Market Share by Country in 2021
Figure 51. Germany Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Blood Coagulants Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Blood Coagulants Revenue Market Share by Country in 2021
Figure 58. Egypt Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Blood Coagulants Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Blood Coagulants in 2021
Figure 64. Manufacturing Process Analysis of Blood Coagulants
Figure 65. Industry Chain Structure of Blood Coagulants
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...